5,170
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Pharmacogenomics and Bioinformatics: Pharmgkb

, &
Pages 501-505 | Published online: 29 Mar 2010

Bibliography

  • Klein TE , ChangJT, ChoMK et al.: Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base.Pharmacogenomics J.1(3) , 167–170 (2001).
  • Lin Z , OwenAB, AltmanRB: Genetics. Genomic research and human subject privacy.Science305(5681) , 183 (2004).
  • Rhead B , KarolchikD, KuhnRM et al.: The UCSC genome browser database: update 2010.Nucleic Acids Res.38(Database issue) , D613–D619 (2009).
  • Wishart DS , KnoxC, GuoAC et al.: DrugBank: a comprehensive resource for in silico drug discovery and exploration.Nucleic Acids Res.34(Database issue) , D668–D672 (2006).
  • Luciano JS : PAX of mind for pathway researchers.Drug Discov. Today10(13) , 937–942 (2005).
  • Giacomini KM , BrettCM, AltmanRB et al.: The pharmacogenetics research network: from SNP discovery to clinical drug response.Clin. Pharmacol. Ther.81(3) , 328–345 (2007).
  • Whirl-Carrillo M , WoonM, ThornCF, KleinTE, AltmanRB: An XML-based interchange format for genotype–phenotype data.Hum. Mutat.29(2) , 212–219 (2008).
  • Klein TE , AltmanRB, ErikssonN et al.: Estimation of the warfarin dose with clinical and pharmacogenetic data.N. Engl. J. Med.360(8) , 753–764 (2009).
  • Owen RP , AltmanRB, KleinTE: PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.Hum. Mutat.29(4) , 456–460 (2008).
  • Altman RB , FlockhartDA, SherryST, OliverDE, RubinDL, KleinTE: Indexing pharmacogenetic knowledge on the World Wide Web.Pharmacogenetics13(1) , 3–5 (2003).
  • Garten Y , AltmanRB: Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text.BMC Bioinformatics10(Suppl. 2) , S6 (2009).
  • Sangkuhl K , BerlinDS, AltmanRB, KleinTE: PharmGKB: understanding the effects of individual genetic variants.Drug Metab. Rev.40(4) , 539–551 (2008).
  • Yu W , NedR, WulfA, LiuT, KhouryMJ, GwinnM: The need for genetic variant naming standards in published abstracts of human genetic association studies.BMC Res. Notes2 , 56 (2009).
  • Owen RP , SangkuhlK, KleinTE, AltmanRB: Cytochrome P450 2D6.Pharmacogenet. Genomics19(7) , 559–562 (2009).
  • Hildebrandt M , AdjeiA, WeinshilboumR: et al.: Very important pharmacogene summary: sulfotransferase 1A1.Pharmacogenet. Genomics19(6) , 404–406 (2009).
  • Thorn CF , KleinTE, AltmanRB: PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.Pharmacogenet. Genomics20(2) , 143–146 (2009).
  • Hodges LM , MarkovaSM, ChinnLW et al.: Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).Pharmacogenet. Genomics PMID: 20216335 (2010) (Epub ahead of print).
  • Wang L , PelleymounterL, WeinshilboumR et al.: Very important pharmacogene summary: thiopurine S-methyltransferase.Pharmacogenet. Genomics PMID: 20154640 (2010) (Epub ahead of print).
  • van Booven D , MarshS, McLeodH et al.: Cytochrome P450 2C9–CYP2C9.Pharmacogenet. Genomics. PMID: 20150829 20(4) , 277–281 (2010).
  • Oshiro C , ThornCF, RodenDM, KleinTE, AltmanRB: KCNH2 pharmacogenomics summary.Pharmacogenet. Genomics PMID: 20150828 (2010) (Epub ahead of print).
  • Medina MW , SangkuhlK, KleinTE, AltmanRB: PharmGKB: very important pharmacogene – HMGCR.Pharmacogenet. Genomics PMID: 20084049 (2010) (Epub ahead of print).
  • Owen RP , GongL, SagrieyaH, KleinTE, AltmanRB: VKORC1 pharmacogenomics summary.Pharmacogenet. Genomics PMID: 19940803 (2009) (Epub ahead of print).
  • Litonjua AA , GongL, DuanQL et al.: Very important pharmacogene summary ADRB2.Pharmacogenet. Genomics20(1) , 64–69 (2010).
  • Berlin DS , PersonMG, MittalA et al.: DNATwist: a web-based tool for teaching middle and high school students about pharmacogenomics.Clin. Pharmacol. Ther. (2010) (In Press).
  • Crowley JJ , SullivanPF, McLeodHL: Pharmacogenomic genome-wide association studies: lessons learned thus far.Pharmacogenomics10(2) , 161–163 (2009).
  • Goldstein DB : Common genetic variation and human traits.N. Engl. J. Med.360(17) , 1696–1698 (2009).
  • Nelson MR , BacanuSA, MostellerM et al.: Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.Pharmacogenomics J.9(1) , 23–33 (2009).
  • Tabone T : Mutations, structural variations, and genome-wide resequencing: where to from here in our understanding of disease and evolution?Hum. Mutat.29(6) , 886–890 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.